Accreditation
Provider Statement
Provided by HMP Education, an HMP Global Company.
Intended Learners
This activity has been designed to meet the educational needs of DEA-registered physicians, pharmacists, advanced practice registered nurses, registered nurses, physician assistants, and practitioners who participate in the diagnosis, prescribing, and treatment of patients.
Learning Objectives
After completing this activity, participants should be able to:
-
Discuss recent updates in prevention, recognition, and care of people with substance and opioid use disorders
-
Recommend best practices for pain management and opioid addiction
-
Outline effective treatments and programs that assist in the management of patients with opioid or other substance use disorders
Activity Overview
To be eligible for documentation of credit, participants must attend the full activity and submit a completed evaluation form. Participants who complete the evaluation online within 1 year of the training will receive immediate documentation of credit. For questions regarding this educational activity, please email accreditation@hmpglobal.com.
Release Date: May 1-September 22, 2023, 2023, as noted on individual session descriptions
Expiration Date: May 1, 2026
Estimated Time to Complete: 16.00 hours. See individual courses for credit amounts.
Hardware/Software Requirements
The activity is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications.
Continuing Education
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.
Physicians
HMP Education designates this enduring activity for 16.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists
This live, knowledge-based activity (Universal Activity Number JA0006201-0000-23-078-H01-P) has been approved for 16.00 contact hours (16.00 CEUs).
The certificate is not the official record of your participation in the activity. The official record of credit will be the information in the CPE Monitor system. Following ACPE Policy, HMP Education must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity. HMP Education is not able to report your claimed credit after this 60-day period. Eligibility for pharmacy credit is contingent upon the successful completion of a post-test and/or evaluation for each activity or session attended.
Nurses
This continuing nursing education enduring activity awards 16.00 contact hours. Provider approved by the California Board of Registered Nursing, Provider #13255 for contact hours.
Nurse Practitioners
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
Physician Assistants
HMP Education has been authorized by the American Academy of Physician Assistants (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This enduring activity is designated for 16.00 AAPA Category 1 credits. PAs should only claim credit commensurate with the extent of their participation
Use Of Proprietary Names
This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.
Unapproved And/Or Investigations Uses of Drugs and Devices
This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of HMP Education.
Disclaimers
The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own health care provider.
The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
Disclosure of Relevant Financial Relationships
HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real relevant financial relationship (conflicts of interest) between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME and CPME.
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
- Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
- Any investigational, off-label, or non-FDA approved content or discussion
HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
Education has been independently peer-reviewed to validate content, mitigate identified financial relationships (conflicts of interest), and ensure:
- All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
- Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
All relevant financial relationships have been mitigated.
Faculty
The faculty has reported the following:
Martin Cheatle, PhD: Consultant – Sana Health; grant/research support –San Health, Inc.
Kelly Clark, MD, MBA: Advisory board – Bicycle Health; consultant – Bicycle Health
Leigh Ann de Monredon: Assistant trainer-Fluence Training Institute
Charlene M. Dewey, MD, MEd, MACP — SVMIC (Self): Consultant | PCORI, MESRE (Self): Grant/Research Support | HCA, Heart Flow, Compass Pathways (Spouse/Partner): Major Stock Shareholder
David Dickerson, MD ― Abbott Laboratories (Self): Consultant (Status: Ongoing); Myovant Biosciences (Self): Consultant (Status: Ongoing); Nalu medical (Self): Consultant (Status: Ongoing); Pfizer (Self): Consultant (Status: Ongoing); SPR therapeutics (Self): Consultant (Status: Ongoing); Vertos Medical
Eric L. Garland, PhD, LCSW ― BehaVR, LLC (Other Financial or Material Support, BehaVR has licensed content from Eric Garland to develop a virtual reality treatment for addiction)
Mark Hamner, MD: Consultant—Otsuka; Research Support—Otsuka.
Arwen Podesta: Advisory Board-Sage Surfer; Advisory Board-NAD+ Research; Advisory Board-JayMac; Affiliate-Collaborator—Psychiatry Redefined; Speakers Bureau—Alkermes, Indivior, and Pear Therapeutics
Brett Snodgrass, FNP-C, ACHPN, FAANP: Salix Pharmaceuticals —Speaker’s Bureau
Robert Valuck, PhD, RPh, FNAP ― RxAssurance Corporation (dba OpiSafe) (self): major stockholder
Clinical Reviewers
William C. Torrey, MD
Professor of Psychiatry
Geisel School of Medicine
Lebanon, New Hampshire
Douglas Noordsy, MD
Clinical Professor Director of Lifestyle Psychiatry, Department of Psychiatry & Behavioral Sciences
Stanford University School of Medicine
Palo Alto, California
Planning Committee
Angela Golden, DNP, FNP-C, FAANP
Owner, NP from Home, LLC
dba NP Obesity Treatment Clinic
Assistant Professor (Ret), Northern Arizona University
Vice President, Arizona Nurse Practitioner Council
Past President, American Association of Nurse Practitioners
Munds Park, Arizona
Angela Golden, DNP, FNP-C, FAANP : Advisory Board- Novo Nordisk, Acella, Gelesis, Currax, Lilly, WW, SetPoint. Promotional Speaker—Novo Nordisk, Acella, Currax. Royalties- Springer Royalties
W. Clay Jackson MD, DipTh
Assistant Professor of Clinical Psychiatry and Family Medicine,
University of Tennessee College of Medicine
Memphis, Tennessee
W. Clay Jackson, MD, DipTh: Consultant – Otsuka, Sage
Andrew Penn, RN, MS, NP, CNS, APRN-BC (nurse planner)
Associate Clinical Professor
University of California, San Francisco
San Francisco, California
Mr. Penn: Grant/Research Support—Usona Institute; Salary—Usona Institute.
Susie Seaman, NP, MSN, CWCN, CWS (nurse planner)
Wound Clinic, Family Health Centers of San Diego
San Diego, California
Ms. Seaman has disclosed no relevant financial relationship with any ineligible company (commercial interest).
HMP Education planners and staff include Kristin Ciszeski; Krystal Scharon; Samantha Conforti; Randy Robbin; Doug Edwards; and Andrea Zimmerman, EdD.
No HMP Education planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).
ADA Statement
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity needs accommodations, please call 609.371.1137.
Privacy Policy
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information. Copyright © 2023 by HMP Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.
Grievance Policy
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education, may contact Samantha Joy, Senior Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at accreditation@hmpglobal.com or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Mrs. Joy will review the grievance and respond within 30 days of receiving the complaint.
Commercial Support
No commercial interest provided financial support for this continuing education activity. Emergent BioSolutions provided an educational grant for the original Taking a Team Approach to Opioid Overdose Treatment: Facilities, Patients, and Caregivers session.
Contact Information
For questions regarding this educational activity, please call 609.371.1137 or email accreditation@hmpglobal.com.
Copyright © 2023 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.
Provider Statement
Provided by HMP Education, an HMP Global Company.
Intended Learners
This activity has been designed to meet the educational needs of DEA-registered physicians, pharmacists, advanced practice registered nurses, registered nurses, physician assistants, and practitioners who participate in the diagnosis, prescribing, and treatment of patients.
Learning Objectives
After completing this activity, participants should be able to:
-
Discuss recent updates in prevention, recognition, and care of people with substance and opioid use disorders
-
Recommend best practices for pain management and opioid addiction
-
Outline effective treatments and programs that assist in the management of patients with opioid or other substance use disorders
Activity Overview
To be eligible for documentation of credit, participants must attend the full activity and submit a completed evaluation form. Participants who complete the evaluation online within 1 year of the training will receive immediate documentation of credit. For questions regarding this educational activity, please email accreditation@hmpglobal.com.
Release Date: May 1-September 22, 2023, 2023, as noted on individual session descriptions
Expiration Date: May 1, 2026
Estimated Time to Complete: 16.00 hours. See individual courses for credit amounts.
Hardware/Software Requirements
The activity is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications.
Continuing Education
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.
Physicians
HMP Education designates this enduring activity for 16.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists
This live, knowledge-based activity (Universal Activity Number JA0006201-0000-23-078-H01-P) has been approved for 16.00 contact hours (16.00 CEUs).
The certificate is not the official record of your participation in the activity. The official record of credit will be the information in the CPE Monitor system. Following ACPE Policy, HMP Education must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity. HMP Education is not able to report your claimed credit after this 60-day period. Eligibility for pharmacy credit is contingent upon the successful completion of a post-test and/or evaluation for each activity or session attended.
Nurses
This continuing nursing education enduring activity awards 16.00 contact hours. Provider approved by the California Board of Registered Nursing, Provider #13255 for contact hours.
Nurse Practitioners
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
Physician Assistants
HMP Education has been authorized by the American Academy of Physician Assistants (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This enduring activity is designated for 16.00 AAPA Category 1 credits. PAs should only claim credit commensurate with the extent of their participation
Use Of Proprietary Names
This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.
Unapproved And/Or Investigations Uses of Drugs and Devices
This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of HMP Education.
Disclaimers
The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own health care provider.
The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
Disclosure of Relevant Financial Relationships
HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real relevant financial relationship (conflicts of interest) between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME and CPME.
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
- Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
- Any investigational, off-label, or non-FDA approved content or discussion
HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
Education has been independently peer-reviewed to validate content, mitigate identified financial relationships (conflicts of interest), and ensure:
- All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
- Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
All relevant financial relationships have been mitigated.
Faculty
The faculty has reported the following:
Martin Cheatle, PhD: Consultant – Sana Health; grant/research support –San Health, Inc.
Kelly Clark, MD, MBA: Advisory board – Bicycle Health; consultant – Bicycle Health
Leigh Ann de Monredon: Assistant trainer-Fluence Training Institute
Charlene M. Dewey, MD, MEd, MACP — SVMIC (Self): Consultant | PCORI, MESRE (Self): Grant/Research Support | HCA, Heart Flow, Compass Pathways (Spouse/Partner): Major Stock Shareholder
David Dickerson, MD ― Abbott Laboratories (Self): Consultant (Status: Ongoing); Myovant Biosciences (Self): Consultant (Status: Ongoing); Nalu medical (Self): Consultant (Status: Ongoing); Pfizer (Self): Consultant (Status: Ongoing); SPR therapeutics (Self): Consultant (Status: Ongoing); Vertos Medical
Eric L. Garland, PhD, LCSW ― BehaVR, LLC (Other Financial or Material Support, BehaVR has licensed content from Eric Garland to develop a virtual reality treatment for addiction)
Mark Hamner, MD: Consultant—Otsuka; Research Support—Otsuka.
Arwen Podesta: Advisory Board-Sage Surfer; Advisory Board-NAD+ Research; Advisory Board-JayMac; Affiliate-Collaborator—Psychiatry Redefined; Speakers Bureau—Alkermes, Indivior, and Pear Therapeutics
Brett Snodgrass, FNP-C, ACHPN, FAANP: Salix Pharmaceuticals —Speaker’s Bureau
Robert Valuck, PhD, RPh, FNAP ― RxAssurance Corporation (dba OpiSafe) (self): major stockholder
Clinical Reviewers
William C. Torrey, MD
Professor of Psychiatry
Geisel School of Medicine
Lebanon, New Hampshire
Douglas Noordsy, MD
Clinical Professor Director of Lifestyle Psychiatry, Department of Psychiatry & Behavioral Sciences
Stanford University School of Medicine
Palo Alto, California
Planning Committee
Angela Golden, DNP, FNP-C, FAANP
Owner, NP from Home, LLC
dba NP Obesity Treatment Clinic
Assistant Professor (Ret), Northern Arizona University
Vice President, Arizona Nurse Practitioner Council
Past President, American Association of Nurse Practitioners
Munds Park, Arizona
Angela Golden, DNP, FNP-C, FAANP : Advisory Board- Novo Nordisk, Acella, Gelesis, Currax, Lilly, WW, SetPoint. Promotional Speaker—Novo Nordisk, Acella, Currax. Royalties- Springer Royalties
W. Clay Jackson MD, DipTh
Assistant Professor of Clinical Psychiatry and Family Medicine,
University of Tennessee College of Medicine
Memphis, Tennessee
W. Clay Jackson, MD, DipTh: Consultant – Otsuka, Sage
Andrew Penn, RN, MS, NP, CNS, APRN-BC (nurse planner)
Associate Clinical Professor
University of California, San Francisco
San Francisco, California
Mr. Penn: Grant/Research Support—Usona Institute; Salary—Usona Institute.
Susie Seaman, NP, MSN, CWCN, CWS (nurse planner)
Wound Clinic, Family Health Centers of San Diego
San Diego, California
Ms. Seaman has disclosed no relevant financial relationship with any ineligible company (commercial interest).
HMP Education planners and staff include Kristin Ciszeski; Krystal Scharon; Samantha Conforti; Randy Robbin; Doug Edwards; and Andrea Zimmerman, EdD.
No HMP Education planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).
ADA Statement
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity needs accommodations, please call 609.371.1137.
Privacy Policy
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information. Copyright © 2023 by HMP Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.
Grievance Policy
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education, may contact Samantha Joy, Senior Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at accreditation@hmpglobal.com or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Mrs. Joy will review the grievance and respond within 30 days of receiving the complaint.
Commercial Support
No commercial interest provided financial support for this continuing education activity. Emergent BioSolutions provided an educational grant for the original Taking a Team Approach to Opioid Overdose Treatment: Facilities, Patients, and Caregivers session.
Contact Information
For questions regarding this educational activity, please call 609.371.1137 or email accreditation@hmpglobal.com.
Copyright © 2023 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.